Latest news
Intellia Q2 Loss Widens to $106.6 Million as Lonvo-z Advances - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:51:00 GMTIntellia Therapeutics Reports Positive Phase 3 HAELO Data for Lonvo-z, Advances Nex-z Trials and Reaffirms Cash Runway Into 2028 - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMTIntellia Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 6 - Quiver QuantitativeQuiver Quantitative · Thu, 30 Jul 2026 07:00:00 GMT